{"id":9898,"date":"2019-10-24T14:00:00","date_gmt":"2019-10-24T09:00:00","guid":{"rendered":"http:\/\/umang.pk\/2019\/10\/houston-company-receives-1-5m-grant-for-urine-test-to-combat-opioid-crisis\/"},"modified":"2019-10-24T14:00:00","modified_gmt":"2019-10-24T09:00:00","slug":"houston-company-receives-1-5m-grant-for-urine-test-to-combat-opioid-crisis","status":"publish","type":"post","link":"https:\/\/umang.pk\/ur\/2019\/10\/24\/houston-company-receives-1-5m-grant-for-urine-test-to-combat-opioid-crisis\/","title":{"rendered":"Houston company receives $1.5M grant for urine test to combat opioid crisis"},"content":{"rendered":"<div>\n        <!-- hearst\/article\/types\/story_body_r2.tpl --><\/p>\n<p><!-- gallery --><\/p>\n<div class=\"asset_gallery\" data-config-asset-position=\"1\" data-gid=\"gallery\"><!-- gallery float --><\/p>\n<p>                        <!-- hearst\/gallery\/main.tpl --><\/p>\n<div class=\"hst-resgallery-container non-grid static-frame\" data-id=\"article-gallery-14556944\" data-title=\"Houston company receives $1.5M grant for urine test to combat opioid crisis\" data-gallery-mode=\"standard\">\n<div class=\"hst-resgallery-wedge\">\n<ul class=\"hst-resgallery non-grid\">\n<li class=\"hst-resgalleryitem \" data-item-id=\"photo-17127172\" data-frame-index=\"0\">\n<div class=\"img-wrap landscape\">\n        \n    <\/div>\n<div class=\"caption \">\n        <!-- design\/gallery\/caption_redesign.tpl --><\/p>\n<p>Houston-based BreviTest Technologies is developing a urine test to help determine if someone is abusing an opioid prescription.<\/p>\n<p>Houston-based BreviTest Technologies is developing a urine test to help determine if someone is abusing an opioid prescription.<\/p>\n<p>    <!-- e design\/gallery\/caption_redesign.tpl --><\/p>\n<p>        <!-- design\/gallery\/caption_redesign.tpl --><br \/>\n                                                                <span class=\"credit\">                                                                                                                                                                                                                                                Photo: Handout, AFP \/ Getty Images<br \/>\n                                                    <\/span><\/p>\n<p>    <!-- e design\/gallery\/caption_redesign.tpl --><\/p><\/div>\n<\/li>\n<\/ul><\/div>\n<div class=\"hst-resgallerynav small hidden\">\n<div class=\"carousel\">\n<ul class=\"clearfix\">\n<li class=\"thumb selected\" data-frame-index=\"0\"><img decoding=\"async\" src=\"http:\/\/umang.pk\/wp-content\/uploads\/2019\/10\/1571912064_376_Houston-company-receives-1.5M-grant-for-urine-test-to-combat.jpg\" class=\"icon-thumb\" alt=\"Picture\" title=\"\"><\/li>\n<\/ul><\/div>\n<\/p><\/div>\n<div class=\"control-panel\">\n\t\t<span id=\"gallerySection\" data-gallery-section=\"\"\/><\/p>\n<div class=\"control-panel-inner\">\n<div class=\"control-bar\">\n<div class=\"control-bar-left\">\n<p>\n                                                    <!-- design\/gallery\/caption_redesign.tpl --><br \/>\n                                                                <span class=\"credit\">                                                                                                                                                                                                                                                Photo: Handout, AFP \/ Getty Images<br \/>\n                                                    <\/span><\/p>\n<p>    <!-- e design\/gallery\/caption_redesign.tpl --><\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"caption\">\n<div class=\"caption-remote\">\n                                            <!-- design\/gallery\/caption_redesign.tpl --><\/p>\n<p>Houston-based BreviTest Technologies is developing a urine test to help determine if someone is abusing an opioid prescription.<\/p>\n<p>Houston-based BreviTest Technologies is developing a urine test to help determine if someone is abusing an opioid prescription.<\/p>\n<p>    <!-- e design\/gallery\/caption_redesign.tpl --><br \/>\n<!-- design\/gallery\/caption_redesign.tpl --><br \/>\n                                                                <span class=\"credit\">                                                                                                                                                                                                                                                Photo: Handout, AFP \/ Getty Images<br \/>\n                                                    <\/span><\/p>\n<p>    <!-- e design\/gallery\/caption_redesign.tpl --><\/p><\/div>\n<\/p><\/div>\n<p>            <!-- hearst\/ads\/medium_rectangle_ad_gallery.tpl --><\/p>\n<p><!-- e hearst\/ads\/medium_rectangle_ad_gallery.tpl -->\t\t<\/div>\n<\/p><\/div>\n<div class=\"gallery-overlay-outer gallery-overlay-outter lights-on hidden\">\n<div class=\"gallery-overlay-inner\">\n<div class=\"gallery-overlay-title-container\">\n<p>Houston Company Receives $ 1.5 Million Urine Testing Subsidy to Fight Opioid Crisis<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<p><!-- e hearst\/gallery\/main.tpl -->                                    <\/div>\n<p><!-- \/gallery float --><br \/>\n                                <!-- fixed --><\/p>\n<p>                        <!-- text --><\/p>\n<p>Houston-based BreviTest Technologies received a $ 1.5 million grant to commercialize a urine test, which helps determine whether someone has been misused or addicted to opioid prescriptions.<\/p>\n<p>    <!-- text --><\/p>\n<p>Tissue box-sized devices can determine the amount of opioid that a patient takes within 10 to 15 minutes.<\/p>\n<p>    <!-- text --><\/p>\n<p>Michael Heffernan, director of product development at BreviTest, said, \u201cThis helps doctors better understand what patients have been taking recently.\u201d &quot;I want to be able to match what patients are saying.&quot;<\/p>\n<p>    <!-- text --><\/p>\n<p><strong>Related: HCA Houston area, opioid recovery day &amp; # 39; crisis crisis &amp; # 39;<\/strong><\/p>\n<p>    <!-- zone --><\/p>\n<p>                    <!-- text --><\/p>\n<p>If a patient claims to take medicine, but the urine sample does not contain opioids, there may be a concern that an individual is selling prescription drugs.<\/p>\n<p>    <!-- fixed --><\/p>\n<p>            <!-- fixed --><br \/>\n                                <!-- hearst\/ads\/duplicatable.tpl --><\/p>\n<p><!-- \/ hearst\/ads\/duplicatable.tpl -->            <!-- text --><\/p>\n<p>According to the Centers for Disease Control and Prevention, opioids died in 47,600 overdose in 2017. Urine drug testing is one of the guidelines of government agencies for prescribing opioids in a safe way, but for doctors who do not have an in-house laboratory, current techniques can take days. It can be a painful delay for people who are uncomfortable for patients and actually suffer from chronic pain. This has led doctors to rarely use urine drug tests, Heffernan said.<\/p>\n<p>    <!-- text --><\/p>\n<p>BreviTest, created by Fannin Innovation Studio, hopes to be the solution. The organization will continue to develop devices using grants from the National Drug Abuse Institute, along with funding from Small Business Innovation Research Phase II grants.<\/p>\n<p><!-- e hearst\/article\/types\/story_body_r2.tpl -->    <\/div>\n<\/pre>\n<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>Houston-based BreviTest Technologies is developing a urine test to help determine if someone is abusing an opioid prescription. Houston-based BreviTest Technologies is developing a urine test to help determine if someone is abusing an opioid prescription. Photo: Handout, AFP \/ Getty Images Photo: Handout, AFP \/ Getty Images Houston-based BreviTest Technologies is developing a urine [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":9899,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9898","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/umang.pk\/ur\/wp-json\/wp\/v2\/posts\/9898","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/umang.pk\/ur\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/umang.pk\/ur\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/umang.pk\/ur\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/umang.pk\/ur\/wp-json\/wp\/v2\/comments?post=9898"}],"version-history":[{"count":0,"href":"https:\/\/umang.pk\/ur\/wp-json\/wp\/v2\/posts\/9898\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/umang.pk\/ur\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/umang.pk\/ur\/wp-json\/wp\/v2\/media?parent=9898"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/umang.pk\/ur\/wp-json\/wp\/v2\/categories?post=9898"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/umang.pk\/ur\/wp-json\/wp\/v2\/tags?post=9898"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}